Brock Reeve

About

Brock had a leadership role in formation of the regenerative medicine field as Executive Director of the Harvard Stem Cell Institute from 2006-2021. In that time period, the number of affiliated faculty grew to 375 and the number of related spin-off companies surpassed 40. Brock was also the CEO of IVIVA Medical, an HSCI faculty spin-off, from 2018 to 2021 leading to a successful acquisition. He currently represents Eos on the board of many of its portfolio companies.

Source (opens in a new tab)